               SEQUENCE LISTING

<110> Universitätsklinikum Regensburg

<120> Anti human IL-3 antibodies, and their use in treatment of a disease or malfunction associated with elevated expression or levels of IL-3, and their use in a method to detect human IL-3

<130> UNR161101PCT

<150> EP16172551.0
<151> 2016-06-01
<150> EP15194062.4
<151> 2015-11-11

<160> 12

<170> BiSSAP 1.3.6

<210> 1
<211> 27
<212> PRT
<213> Artificial Sequence


<220> 
<223> aa 22-48 of human IL-3 without signal peptide

<400> 1
Glu Ile Ile Thr His Leu Lys Gln Pro Pro Leu Pro Leu Leu Asp Phe 
1               5                   10                  15      
Asn Asn Leu Asn Gly Glu Asp Gln Asp Ile Leu 
            20                  25          

<210> 2
<211> 27
<212> PRT
<213> Artificial Sequence


<220> 
<223> aa 1-27 of human IL-3 without signal peptide

<400> 2
Ala Pro Met Thr Gln Thr Thr Pro Leu Lys Thr Ser Trp Val Asn Cys 
1               5                   10                  15      
Ser Asn Met Ile Asp Glu Ile Ile Thr His Leu 
            20                  25          

<210> 3
<211> 24
<212> PRT
<213> Artificial Sequence


<220> 
<223> aa 1-24 of human IL-3 without signal peptide

<220> 
<221> VARIANT
<222> 14
<223> mutation V to A

<220> 
<221> VARIANT
<222> 15
<223> mutation N to K

<400> 3
Ala Pro Met Thr Gln Thr Thr Pro Leu Lys Thr Ser Trp Ala Lys Cys 
1               5                   10                  15      
Ser Asn Met Ile Asp Glu Ile Ile 
            20                  

<210> 4
<211> 24
<212> PRT
<213> Artificial Sequence


<220> 
<223> aa 1-24 of human IL-3 without signal peptide

<220> 
<221> VARIANT
<222> 8
<223> mutation P to S

<400> 4
Ala Pro Met Thr Gln Thr Thr Ser Leu Lys Thr Ser Trp Val Asn Cys 
1               5                   10                  15      
Ser Asn Met Ile Asp Glu Ile Ile 
            20                  

<210> 5
<211> 27
<212> PRT
<213> Artificial Sequence


<220> 
<223> aa 43-69 of human IL-3 without signal peptide

<400> 5
Glu Asp Gln Asp Ile Leu Met Glu Asn Asn Leu Arg Arg Pro Asn Leu 
1               5                   10                  15      
Glu Ala Phe Asn Arg Ala Val Lys Ser Leu Gln 
            20                  25          

<210> 6
<211> 27
<212> PRT
<213> Artificial Sequence


<220> 
<223> aa 64-90 of human IL-3 without signal peptide

<400> 6
Ala Val Lys Ser Leu Gln Asn Ala Ser Ala Ile Glu Ser Ile Leu Lys 
1               5                   10                  15      
Asn Leu Leu Pro Cys Leu Pro Leu Ala Thr Ala 
            20                  25          

<210> 7
<211> 27
<212> PRT
<213> Artificial Sequence


<220> 
<223> aa 85-111 of human IL-3 without signal peptide

<400> 7
Leu Pro Leu Ala Thr Ala Ala Pro Thr Arg His Pro Ile His Ile Lys 
1               5                   10                  15      
Asp Gly Asp Trp Asn Glu Phe Arg Arg Lys Leu 
            20                  25          

<210> 8
<211> 28
<212> PRT
<213> Artificial Sequence


<220> 
<223> aa 106-133 of human IL-3 without signal peptide

<400> 8
Glu Phe Arg Arg Lys Leu Thr Phe Tyr Leu Lys Thr Leu Glu Asn Ala 
1               5                   10                  15      
Gln Ala Gln Gln Thr Thr Leu Ser Leu Ala Ile Phe 
            20                  25              

<210> 9
<211> 19
<212> PRT
<213> Artificial Sequence


<220> 
<223> aa 30-48 of human IL-3 without signal peptide

<400> 9
Pro Pro Leu Pro Leu Leu Asp Phe Asn Asn Leu Asn Gly Glu Asp Gln 
1               5                   10                  15      
Asp Ile Leu 
            

<210> 10
<211> 133
<212> PRT
<213> Artificial Sequence


<220> 
<223> human IL-3 without signal peptide

<400> 10
Ala Pro Met Thr Gln Thr Thr Ser Leu Lys Thr Ser Trp Val Asn Cys 
1               5                   10                  15      
Ser Asn Met Ile Asp Glu Ile Ile Thr His Leu Lys Gln Pro Pro Leu 
            20                  25                  30          
Pro Leu Leu Asp Phe Asn Asn Leu Asn Gly Glu Asp Gln Asp Ile Leu 
        35                  40                  45              
Met Glu Asn Asn Leu Arg Arg Pro Asn Leu Glu Ala Phe Asn Arg Ala 
    50                  55                  60                  
Val Lys Ser Leu Gln Asn Ala Ser Ala Ile Glu Ser Ile Leu Lys Asn 
65                  70                  75                  80  
Leu Leu Pro Cys Leu Pro Leu Ala Thr Ala Ala Pro Thr Arg His Pro 
                85                  90                  95      
Ile His Ile Lys Asp Gly Asp Trp Asn Glu Phe Arg Arg Lys Leu Thr 
            100                 105                 110         
Phe Tyr Leu Lys Thr Leu Glu Asn Ala Gln Ala Gln Gln Thr Thr Leu 
        115                 120                 125             
Ser Leu Ala Ile Phe 
    130             

<210> 11
<211> 23
<212> PRT
<213> Artificial Sequence


<220> 
<223> aa 26-48 of human IL-3 without signal peptide

<400> 11
His Leu Lys Gln Pro Pro Leu Pro Leu Leu Asp Phe Asn Asn Leu Asn 
1               5                   10                  15      
Gly Glu Asp Gln Asp Ile Leu 
            20              

<210> 12
<211> 21
<212> PRT
<213> Artificial Sequence


<220> 
<223> aa 28-48 of human IL-3 without signal peptide

<400> 12
Lys Gln Pro Pro Leu Pro Leu Leu Asp Phe Asn Asn Leu Asn Gly Glu 
1               5                   10                  15      
Asp Gln Asp Ile Leu 
            20      

